Abstract:Purpose PCLS from lung resections or explants have gained increasing attention as novel human disease models and to overcome limitations of acellular scaffold models. This method is appropriate for the assessment of new drug efficacy and the evaluation of cellular drug targets in a whole tissue model. We have recently developed and patented functionalized liposomes, named “xhalip”, loaded with tyrosine kinase inhibitors for the inhalatory treatment of Chronic Lung Allograft Dysfunction (CLAD) and other form of immune-inflammatory lung fibrosis. Methods To assess the anti-remodeling action of xhalip, we developed and applied an Endothelial Mesenchymal Transition (EMT) model of PCLS obtained from healthy non smokers-lung tissue (from graft volume reduction/lobectomy for malignancy). PCLS were treated either with a “fibrogenic cocktail” composed by platelet lysate (PL) and TGFbeta (10ng/ml), or purified NETs (from 2.5 × 106 neutrophils activated with PMA). Gene expression of α-SMA (ACTA2), type 1a1 collagen (COL1A1) and type3a1 collagen (COL3A1) was monitored up to 96 hours to reveal development of EMT. Results ACTA2 expression was significant up-regulated by NETs compared to control cells (2-fold at 48 hrs and 3-fold increase at 72 hrs, p<0.01), as well as PL+TGFbeta treatment (2.5-fold at 48 hrs and 2-fold increase at 72 hrs, p<0.01). We also observed significant upregulation at 48 h of COL1A1 and COL3A1, up to 96 hrs only with PL+ TGFbeta treatment. Treatment of stimulated PCLS with HA-coated and Imatinib-loaded xhalip, or with free drug imatinib, was associated to a significant reduction of ACTA2 (70-50% decrease at 48 hrs with xhalip and 50-30% for Im at 48 and 72 hrs respectively), COL1A1 (60%-10% with both treatment at 48 and 72 hrs) and COL3A1 (reduced by 40% and 5% with both treatment at 48 and 72 hrs, respectively). Conclusion In conclusion, human-derived PCLS, can allow the assessment of new therapeutic strategies on an ex vivo EMT model. Imatinib-loaded xhalip are a promising strategy for the local treatment of CLAD, in particular of the obstructive phenotype.

In Situ Forming Chitosan-Based Hydrogel As a Lung Sealant for Biological Lung Volume Reduction

A Bionic Controllable Strain Membrane for Cell Stretching at Air–liquid Interface Inspired by Papercutting

Lung-Mimetic Hydrofoam Sealant to Treat Pulmonary Air Leak

A Chitosan Hydrogel Sealant with Self-Contractile Characteristic: from Rapid and Long-Term Hemorrhage Control to Wound Closure and Repair.

Swellable and Thermally Responsive Hydrogel/Shape Memory Polymer Foam Composites for Sealing Lung Biopsy Tracts

In Vivo Validation of Biological Responses of Bfgf Released from Microspheres Formulated by Blending Poly-Lactide-co-Glycolide and Poly(ethylene Glycol)-Grafted-chitosan in Hamster Cheek Pouch Microcirculatory Models

The Preparation of the Ordered Pores Colloidal Crystal Scaffold and Its Role in Promoting Growth of Lung Cells.

Hollow fiber membrane modification with functional zwitterionic macromolecules for improved thromboresistance in artificial lungs.

Comparison of morphological and functional restoration between asymmetric bilayer chitosan and bladder acellular matrix graft for bladder augmentation in a rat model

Immunotherapeutic hydrogel for co-delivery of STAT3 siRNA liposomes and lidocaine hydrochloride for postoperative comprehensive management of NSCLC in a single application

A self-fused hydrogel for the treatment of glottic insufficiency through outstanding durability, extracellular matrix-inducing bioactivity and function preservation

Assessment of a novel lung sealant for performing endoscopic volume reduction therapy in patients with advanced emphysema

Successful Bronchoscopic Lung Volume Reduction with New Lung Tensioning Device Coil: A Case Report

In Situ Bioorthogonal Repair of the Vascular Endothelium Glycocalyx to Treat Acute Lung Injury

Cross-linked hydrogel and polyester resorbable ventilation tubes in a Chinchilla model

Assessment of an Innovative Liposomal Preparations on Precision-Cut Lung Slices (PCLS): An Ex-Vivo Model of EMT

Injectable and self-healing sulfated hyaluronic acid/gelatin hydrogel as dual drug delivery system for circumferential tracheal repair

Preliminary study on lung volume reduction by bronchial occlusion with pingyangmycin-lipiodol emulsion

Tissue-engineered lung: an in vivo and in vitro comparison of polyglycolic acid and pluronic F-127 hydrogel/somatic lung progenitor cell constructs to support tissue growth

Novel in situ forming hydrogel based on xanthan and chitosan re-gelifying in liquids for local drug delivery.

Creation of a uniform pleural defect model for the study of lung sealants